Terug
29
Dagbereik
€ 36,80
€ 37,67
52-Weeksbereik
€ 19,17
€ 37,67
Volume
225.950
50D / 200D Gem.
€ 32,28
/
€ 27,21
Vorige Slotkoers
€ 37,26
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 48,4 | 0,4 |
| P/B | 11,6 | 2,9 |
| ROE % | 28,3 | 3,9 |
| Net Margin % | 3,4 | 3,8 |
| Rev Growth 5Y % | 16,3 | 10,0 |
| D/E | 0,2 | 0,2 |
Koersdoel Analisten
Hold
€ 36,00
-4.2%
Low: € 30,00
High: € 40,00
Forward K/W
30,17
Forward WPA
€ 1,24
WPA Groei (sch.)
+0,0%
Omzet Sch.
1,41B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 1,46
€ 1,44 – € 1,48
|
1,68B | 2 |
| FY2027 |
€ 1,36
€ 1,31 – € 1,40
|
1,53B | 3 |
| FY2026 |
€ 1,24
€ 1,21 – € 1,25
|
1,41B | 3 |
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 16,29% annually over 5 years — strong growth
ROE of 28,25% indicates high profitability
Debt/Equity of 0,22 — conservative balance sheet
Generating 80,71M in free cash flow
P/E of 48,35 — premium valuation
Cash machine — converts 163,98% of earnings into free cash flow
Groei
Revenue Growth (5Y)
16,29%
Revenue (1Y)17,93%
Earnings (1Y)N/A
FCF Growth (3Y)19,77%
Kwaliteit
Return on Equity
28,25%
ROIC26,62%
Net Margin3,40%
Op. Margin6,14%
Veiligheid
Debt / Equity
0,22
Current Ratio1,38
Interest Coverage133,71
Waardering
P/E Ratio
48,35
Forward P/EN/A
P/B Ratio11,57
EV/EBITDA26,53
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17,93% | Revenue Growth (3Y) | 17,67% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | 43,50% |
| Revenue Growth (5Y) | 16,29% | Earnings Growth (5Y) | 31,79% |
| Profitability | |||
| Revenue (TTM) | 1,45B | Net Income (TTM) | 49,22M |
| ROE | 28,25% | ROA | 11,93% |
| Gross Margin | 19,47% | Operating Margin | 6,14% |
| Net Margin | 3,40% | Free Cash Flow (TTM) | 80,71M |
| ROIC | 26,62% | FCF Growth (3Y) | 19,77% |
| Safety | |||
| Debt / Equity | 0,22 | Current Ratio | 1,38 |
| Interest Coverage | 133,71 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 48,35 | Forward P/E | N/A |
| P/B Ratio | 11,57 | P/S Ratio | 1,64 |
| PEG Ratio | -0,26 | Forward PEG | N/A |
| EV/EBITDA | 26,53 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 3,39% | ||
| Market Cap | 2,38B | Enterprise Value | 2,36B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,45B | 1,23B | 1,05B | 908,91M | 792,07M |
| Net Income | 49,22M | -87,29M | 23,90M | 35,42M | 16,31M |
| EPS (Diluted) | 0,78 | -1,77 | 0,39 | 0,58 | 0,27 |
| Gross Profit | 282,04M | 244,37M | 208,31M | 185,87M | 161,27M |
| Operating Income | 88,91M | -62,92M | 40,95M | 51,99M | 30,15M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 412,66M | 320,81M | 271,17M | 256,11M | 235,85M |
| Total Liabilities | 194,73M | 170,83M | 211,31M | 180,18M | 182,53M |
| Shareholders' Equity | 205,76M | 142,67M | 28,21M | 42,73M | 23,93M |
| Total Debt | 44,72M | 37,33M | 69,15M | 62,98M | 55,04M |
| Cash & Equivalents | 65,62M | 4,66M | 752.000,0 | 607.000,0 | 15,01M |
| Current Assets | 221,63M | 151,99M | 129,60M | 120,00M | 111,87M |
| Current Liabilities | 160,70M | 144,12M | 138,02M | 112,01M | 111,54M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#856 of 1052
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026